Hannover Messe is held annually in Hannover on the world’s largest exhibition grounds. This year’s fair highlighted key advancements in industrial development, with a strategic focus on Artificial Intelligence.
Representing the IML department at the DFKI booth, Robert Leist showcased the OphthalmoAI project alongside colleagues Siting Liang and Tuan Tran, and Professor Daniel Sonntag. The team demonstrated the OphthalmoCDSS prototype – a Clinical Decision Support System designed to assist ophthalmologists through three core AI functionalities: biomarker localization, disease progression forecasting, and treatment recommendations [1, 2].
The exhibit attracted high-profile interest, including visits from Rianne Letschert, the Dutch Minister of Education, Culture and Science; Ina Czyborra, Berlin’s Senator for Science, Health, and Care; and Bundestag members Tilman Kuban and Sebastian Lechner. Furthermore, DFKI CEO Antonio Krüger featured the prototype during an interview with Aktueller Bericht on Saarländischer Rundfunk.
At the well attended fair, the researchers were able to present their work and establish important industry contacts.
left: Robert Leist presents the prototype to CEO Antonio Krüger and the SR; right: Robert Leist and Daniel Sonntag present the prototype to dutch minister, Rianne Leschert (with Thiago Gouvea from IML) (©DFKI/Armindo Ribeiro)
Daniel Sonntag introduces the OphthalmoAI project to Bundestag politician Tilman Kuban (©DFKI/Armindo Ribeiro)
Robert Leist, Siting Liang, and Daniel Sonntag in front of the booth (©DFKI/Jaron Hollax)
Sources:
1 – Towards Trustable Clinical Decision Support Systems: A User Study with Ophthalmologists
2 – An AI-driven Clinical Decision Support System for the Treatment of Diabetic Retinopathy and Age-related Macular Degeneration